Caxton Associates LP Jazz Pharmaceuticals PLC Transaction History

Caxton Associates LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$87.74 - $152.74 $433,523 - $754,688	-4,941 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$117.65 - $153.73 $196,122 - $256,267	1,667 Added 50.92%	4,941 $738,000
Q3 2019 Nov 14, 2019	BUY	$125.18 - $143.24 $409,839 - $468,967	3,274 New	3,274 $420,000
Q1 2019 May 15, 2019	SELL	$121.81 - $142.95 $222,059 - $260,597	-1,823 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$115.94 - $166.74 $211,358 - $303,967	1,823 New	1,823 $226,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.